Literature DB >> 25535115

Isolation of colorectal cancer stem-like cells.

Eunice Dotse1,2, Yuhong Bian3.   

Abstract

This study is aimed at isolating colorectal cancer stem-like cells in vitro using a neurosphere assay method employed in isolating gliobastoma multiforme tumor cells. This was followed with confirmation of the isolated cells by flow cytometry, pluripotent genes expression and in vivo tumorigenicity assay. Using this culture assay, stem-like and non-stem-like CRC cells were isolated and expanded in vitro from purchased Balb/c mice induced with CT26 colorectal cancer (CRC) cell line. The procedure includes an initial mechanical dissociation and chemical digestion of tumor tissue and subsequently plating the resulting single cell suspension in serum-free medium (SFM) or serum-containing medium (SCM). This selectively permits growth of cancer stem-like cells in SFM and eliminates non-stem-like cancer cells through the process of anoikis or apoptosis. CRC stem cells derived cultures proliferated as non-adherent spheres in vitro in different shapes and sizes. These cells expressed cell surface markers previously reported for tumor stem cells, including CD44, CD133, CD166 and CD26 and formed tumors when implanted in severe combined immunodeficient mice in a concentration dependent manner. Importantly, the stem-like cells had self-renewal properties with significantly higher expression of the pluripotent stem cell genes NANOG, OCT4, and SOX2 compared to the adherent non-stem cells. Collectively, the results of this study indicate that SFM is a defined culture medium that enriches for CRC stem-like cells and represents a suitable in vitro model for the study of CRC stem-like cells. This finding may be useful in developing therapeutic strategies aimed at eradicating the tumorigenic subpopulation within colorectal cancer.

Entities:  

Keywords:  Cancer stem cells; Colorectal cancer; Non-cancer stem cells

Year:  2014        PMID: 25535115      PMCID: PMC4960108          DOI: 10.1007/s10616-014-9806-0

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  35 in total

1.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  Expression of Sox2 in human cervical carcinogenesis.

Authors:  Jing Ji; Peng-Sheng Zheng
Journal:  Hum Pathol       Date:  2010-08-14       Impact factor: 3.466

4.  Genetic variations in stem cell-related genes and colorectal cancer prognosis.

Authors:  Hushan Yang; Falin Qu; Ronald E Myers; Guoqiang Bao; Terry Hyslop; Guang Hu; Fei Fei; Jinliang Xing
Journal:  J Gastrointest Cancer       Date:  2012-12

Review 5.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

6.  Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.

Authors:  Hugo J Snippert; Johan H van Es; Maaike van den Born; Harry Begthel; Daniel E Stange; Nick Barker; Hans Clevers
Journal:  Gastroenterology       Date:  2009-03-24       Impact factor: 22.682

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  The role of colorectal cancer stem cells in metastatic disease and therapeutic response.

Authors:  Eric C Anderson; Crystal Hessman; Trevor G Levin; Marcus M Monroe; Melissa H Wong
Journal:  Cancers (Basel)       Date:  2011-01-01       Impact factor: 6.639

Review 9.  Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target.

Authors:  S Buczacki; R J Davies; D J Winton
Journal:  Br J Cancer       Date:  2011-09-20       Impact factor: 7.640

10.  The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines.

Authors:  Sabrieh Amini; Fardin Fathi; Jafar Mobalegi; Heshmatollah Sofimajidpour; Tayyeb Ghadimi
Journal:  Anat Cell Biol       Date:  2014-03-13
View more
  17 in total

Review 1.  Therapies targeting cancer stem cells: Current trends and future challenges.

Authors:  Denisa L Dragu; Laura G Necula; Coralia Bleotu; Carmen C Diaconu; Mihaela Chivu-Economescu
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

2.  Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.

Authors:  Leila Eini; Marzieh Naseri; Feridoun Karimi-Busheri; Mahmood Bozorgmehr; Roya Ghods; Zahra Madjd
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-30       Impact factor: 4.322

3.  The identification and validation of Trichosstatin A as a potential inhibitor of colon tumorigenesis and colon cancer stem-like cells.

Authors:  Tse-Hung Huang; Szu-Yuan Wu; Yan-Jiun Huang; Po-Li Wei; Alexander Th Wu; Tsu-Yi Chao
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

4.  Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.

Authors:  Hatem O Kaseb; Helene Fohrer-Ting; Dale W Lewis; Eric Lagasse; Susanne M Gollin
Journal:  Exp Cell Res       Date:  2016-09-09       Impact factor: 3.905

Review 5.  Advances in Liver Cancer Stem Cell Isolation and their Characterization.

Authors:  Lu Liu; Jürgen Borlak
Journal:  Stem Cell Rev Rep       Date:  2021-01-11       Impact factor: 5.739

6.  HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.

Authors:  Ye Huang; Liang Wang; Di Liu
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

7.  Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer.

Authors:  Lui Ng; Timothy Wan; Ariel Chow; Deepak Iyer; Johnny Man; Guanghua Chen; Thomas Chung-Cheung Yau; Oswens Lo; Chi-Chung Foo; Jensen Tung-Chung Poon; Ronnie Tung-Ping Poon; Roberta Pang; Wai-Lun Law
Journal:  Stem Cells Int       Date:  2015-05-27       Impact factor: 5.443

Review 8.  Self-renewal molecular mechanisms of colorectal cancer stem cells.

Authors:  Tianhui Pan; Jinghong Xu; Yongliang Zhu
Journal:  Int J Mol Med       Date:  2016-11-30       Impact factor: 4.101

9.  Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.

Authors:  Yan-Jiun Huang; Ching-Kuo Yang; Po-Li Wei; Thanh-Tuan Huynh; Jacqueline Whang-Peng; Tzu-Ching Meng; Michael Hsiao; Yew-Ming Tzeng; Alexander Th Wu; Yun Yen
Journal:  J Hematol Oncol       Date:  2017-02-28       Impact factor: 17.388

10.  Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment.

Authors:  Tatsuya Usui; Masashi Sakurai; Shuhei Enjoji; Hideyoshi Kawasaki; Koji Umata; Takashi Ohama; Nobuyuki Fujiwara; Ryotaro Yabe; Shunya Tsuji; Hideyuki Yamawaki; Shoichi Hazama; Hiroko Takenouchi; Masao Nakajima; Ryouichi Tsunedomi; Nobuaki Suzuki; Hiroaki Nagano; Koichi Sato
Journal:  Stem Cells Int       Date:  2016-12-29       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.